FMR LLC discloses 13.8% Prothena (PRTA) ownership; key fund holds 6.4%
Rhea-AI Filing Summary
FMR LLC reported beneficial ownership of common stock of Prothena Corporation plc. FMR LLC held 7,199,218 shares, representing 13.8% of the outstanding common stock as of June 30, 2026, with sole power to dispose of all such shares and no shared voting or dispositive power.
Abigail P. Johnson is reported with sole dispositive power over the same 7,199,218 shares, but no sole or shared voting power. The filing notes that one or more other persons have rights to receive dividends or sale proceeds, including Fidelity Growth Company Commingled Pool, whose interest amounted to 3,335,877 shares, or 6.4% of Prothena’s common stock as of June 30, 2026.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 7,199,218 shares
Percent of class: 13.8%
Sole dispositive power (FMR LLC): 7,199,218 shares
+4 more
7 metrics
Beneficial ownership
7,199,218 shares
Shares of Prothena common stock beneficially owned by FMR LLC
Percent of class
13.8%
Percentage of Prothena common stock class beneficially owned by FMR LLC
Sole dispositive power (FMR LLC)
7,199,218 shares
Shares over which FMR LLC has sole power to dispose
Sole dispositive power (Abigail P. Johnson)
7,199,218 shares
Shares over which Abigail P. Johnson has sole dispositive power
Fidelity Growth Company Commingled Pool holding
3,335,877 shares
Interest in Prothena common stock held through the commingled pool
Commingled Pool percent of class
6.4%
Percentage of total outstanding Prothena common stock at 06/30/2026
As-of date
06/30/2026
Date for ownership and percentage calculations in the filing
Key Terms
beneficially owned, sole dispositive power, shared voting power, Schedule 13G, +1 more
5 terms
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 7199218.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power financial
"Sole Dispositive Power 7,199,218.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"Please see Exhibit 99 for 13d-1(k) (1) agreement."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
commingled pool financial
"The interest of Fidelity Growth Company Commingled Pool, in the COMMON STOCK"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What percentage of Prothena (PRTA) does FMR LLC control?
FMR LLC reports holding 13.8% of Prothena’s common stock, based on 7,199,218 shares beneficially owned. This position gives FMR LLC sole dispositive power but no shared voting or dispositive authority.
What interest does Fidelity Growth Company Commingled Pool hold in Prothena (PRTA)?
Fidelity Growth Company Commingled Pool’s interest amounted to 3,335,877 shares of Prothena common stock, or 6.4% of total outstanding shares as of June 30, 2026, with rights to dividends or sale proceeds on those shares.
Does any other party have rights to Prothena (PRTA) dividends or sale proceeds?
Yes. One or more other persons have rights to receive dividends or sale proceeds, including Fidelity Growth Company Commingled Pool, whose 3,335,877-share interest equals 6.4% of Prothena’s outstanding common stock as of June 30, 2026.